Advanced pancreatic carcinoma: current treatment and future challengesAnastasios Stathis, Malcolm J. Moore|Nature Reviews Clinical Oncology|2010Cited by 791
A Phase Ib Dose-Escalation Study of the Oral Pan-PI3K Inhibitor Buparlisib (BKM120) in Combination with the Oral MEK1/2 Inhibitor Trametinib (GSK1120212) in Patients with Selected Advanced Solid TumorsPhilippe L. Bédard, Cristiana Sessa, Anastasios Stathis et al.|Clinical Cancer Research|2014Cited by 326
Targeting myeloid chemotaxis to reverse prostate cancer therapy resistanceChristina Guo, Johann S. de Bono, Adam Sharp et al.|Nature|2023Cited by 119
Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumorsAnastasios Stathis, C. Sessa, Dagmar Hess et al.|Investigational New Drugs|2017Cited by 32